Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Komal Jhaveri

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
MARIANNE: Impact on Current Treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Implications for the FutureKomal Jhaveri
Oncotargets and Therapy|August 6, 2015
Ganetespib: research and clinical developmentKomal Jhaveri, Shanu Modi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2014
Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right directionKomal Jhaveri, Hannah Linden
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
HSP90 inhibitors for cancer therapy and overcoming drug resistanceKomal Jhaveri, Shanu Modi
Cancer Treatment Reviews|January 11, 2024
Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancerKomal Jhaveri, Frederik Marmé
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Pertuzumab in the treatment of HER2+ breast cancerKomal Jhaveri, Francisco J Esteva
JCO Oncology Practice|June 10, 2021
Tailoring Therapy to Be Just Right in HER2-Positive Early-Stage Breast Cancer: The Goldilocks ProblemJoshua Z Drago, Komal Jhaveri
Clinical Breast Cancer|June 19, 2023
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future DirectionsNicholas Mai, Nour Abuhadra, Komal Jhaveri
Cancer Discovery|March 3, 2019
Targeting Apoptosis: A New Paradigm for the Treatment of Estrogen Receptor-Positive Breast CancerJoshua Z Drago, Sarat Chandarlapaty, Komal Jhaveri
Biochimica Et Biophysica Acta|November 9, 2011
Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancersKomal Jhaveri, Tony Taldone, Shanu Modi, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
MARIANNE: Impact on Current Treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Implications for the FutureKomal Jhaveri
Oncotargets and Therapy|August 6, 2015
Ganetespib: research and clinical developmentKomal Jhaveri, Shanu Modi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2014
Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right directionKomal Jhaveri, Hannah Linden
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
HSP90 inhibitors for cancer therapy and overcoming drug resistanceKomal Jhaveri, Shanu Modi
Cancer Treatment Reviews|January 11, 2024
Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancerKomal Jhaveri, Frederik Marmé
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Pertuzumab in the treatment of HER2+ breast cancerKomal Jhaveri, Francisco J Esteva
JCO Oncology Practice|June 10, 2021
Tailoring Therapy to Be Just Right in HER2-Positive Early-Stage Breast Cancer: The Goldilocks ProblemJoshua Z Drago, Komal Jhaveri
Clinical Breast Cancer|June 19, 2023
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future DirectionsNicholas Mai, Nour Abuhadra, Komal Jhaveri
Cancer Discovery|March 3, 2019
Targeting Apoptosis: A New Paradigm for the Treatment of Estrogen Receptor-Positive Breast CancerJoshua Z Drago, Sarat Chandarlapaty, Komal Jhaveri
Biochimica Et Biophysica Acta|November 9, 2011
Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancersKomal Jhaveri, Tony Taldone, Shanu Modi, et al.
Pageof 10